Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/112937
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorSchool of Optometry-
dc.creatorLai, C-
dc.creatorSu, T-
dc.creatorCao, J-
dc.creatorLi, Q-
dc.creatorDu, Z-
dc.creatorWang, Y-
dc.creatorWang, S-
dc.creatorWu, Q-
dc.creatorHu, Y-
dc.creatorFang, Y-
dc.creatorLiao, H-
dc.creatorZhu, Z-
dc.creatorShang, X-
dc.creatorHe, M-
dc.creatorYu, H-
dc.creatorZhang, X-
dc.date.accessioned2025-05-15T06:59:07Z-
dc.date.available2025-05-15T06:59:07Z-
dc.identifier.issn0146-0404-
dc.identifier.urihttp://hdl.handle.net/10397/112937-
dc.language.isoenen_US
dc.publisherAssociation for Research in Vision and Ophthalmologyen_US
dc.rightsCopyright 2024 The Authorsen_US
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/).en_US
dc.rightsThe following publication Chunran Lai, Ting Su, Jiahui Cao, Qinyi Li, Zijing Du, Yaxin Wang, Shan Wang, Qiaowei Wu, Yijun Hu, Ying Fang, Huiyi Liao, Zhuoting Zhu, Xianwen Shang, Mingguang He, Honghua Yu, Xiayin Zhang; Retinal Neurovascular Impairment in Full-Course Diabetic Retinopathy: The Guangdong Diabetic Retinopathy Multiple-Omics Study. Invest. Ophthalmol. Vis. Sci. 2024;65(14):20 is available at https://dx.doi.org/10.1167/iovs.65.14.20.en_US
dc.subjectAdaptive opticsen_US
dc.subjectDiabetic retinopathy (DR)en_US
dc.subjectFull-course diabetic retinopathy (full-course DR)en_US
dc.subjectNeurovascular damageen_US
dc.titleRetinal neurovascular impairment in full-course diabetic retinopathy : the Guangdong Diabetic Retinopathy Multiple-omics studyen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.volume65-
dc.identifier.issue14-
dc.identifier.doi10.1167/iovs.65.14.20-
dcterms.abstractPURPOSE. The purpose of this study was to explore the succession of the central and peripheral neurovascular and microstructural impairments in patients with full-course diabetic retinopathy (DR), consisting of preclinical DR, nonproliferative DR (NPDR), and proliferative DR (PDR).-
dcterms.abstractMETHODS. Our analysis included 81 participants (including 23 healthy controls, 23 with preclinical DR [diabetes without retinopathy], 13 with NPDR, and 22 with PDR) from the Guangdong Diabetic Retinopathy Multiple Omics Study. Retinal structure and function were evaluated and quantified using ultra-widefield swept-source optical coherence tomography angiography (UWF-SS-OCTA), electroretinography (ERG), and adaptive optics scanning laser ophthalmoscopy (AOSLO). Correlation analysis was conducted to explore the relationship between structural parameters and functional parameters.-
dcterms.abstractRESULTS. In the preclinical DR group, decreased amplitude in the DR assessment protocol were observed (P = 0.003), with no changes in structure and photoreceptor cells (all P > 0.05). In the NPDR group, photoreceptor cells were impaired (all P < 0.05) with delayed implicit time in the International Society for Clinical Electrophysiology of Vision (ISCEV) Photopic flicker protocol, increased macular and inner nuclear layer thickness, and decreased vessel density and perfusion area of the deep capillary plexus (all P < 0.05). In the PDR group, delayed implicit time and decreased amplitude in the ISCEV Photopic flicker and photopic negative response (PhNR) protocol, and neurovascular impairments were observed (all P < 0.05). Correlation analysis demonstrated a significant correlation between functional parameters and various structural indicators (all P < 0.05).-
dcterms.abstractCONCLUSIONS. The cone pathway function began to decline in preclinical DR and distinct photoreceptor cell disorders were observed in NPDR. Notably, instruments with a wider field of view or more detailed microscopic techniques will provide enhanced neurovascular imaging, offering fresh insights into full-course DR.-
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationInvestigative ophthalmology and visual science, Dec. 2025, v. 65, no. 14, 20-
dcterms.isPartOfInvestigative ophthalmology and visual science-
dcterms.issued2024-12-
dc.identifier.scopus2-s2.0-85212245786-
dc.identifier.pmid39656471-
dc.identifier.eissn1552-5783-
dc.identifier.artn20-
dc.description.validate202505 bcrc-
dc.description.oaVersion of Recorden_US
dc.identifier.FolderNumberOA_Scopus/WOSen_US
dc.description.fundingSourceOthersen_US
dc.description.fundingTextNational Natural Science Foundation of China; China Postdoctoral Science Foundation; the Science and Technology Program of Guangzhou, China; launch fund of Guangdong Provincial People’s Hospital for NSFC; Guangdong Basic and Applied Basic Research Foundation; Medical Scientific Research Foundation of Guangdong Province; Brolucizumab Efficacy and Safety Single-Arm Descriptive Trial in Patients with Persistent Diabetic Macular Edema (BEST)en_US
dc.description.pubStatusPublisheden_US
dc.description.oaCategoryCCen_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
e095 i1552-5783-65-14-20_1733822795.99942.pdf1.01 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

SCOPUSTM   
Citations

6
Citations as of Dec 19, 2025

WEB OF SCIENCETM
Citations

6
Citations as of Dec 18, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.